XELIRI compared with FOLFIRI as a second-line treatment in patients with metastatic colorectal cancer

The aim of this study was to compare the efficacy, safety and survival rate of a treatment regimen comprising capecitabine plus irinotecan (XELIRI) to those of a standard regimen comprising leucovorin, fluorouracil and irinotecan (FOLFIRI), to determine the correlation among the inherited genetic va...

Descripción completa

Detalles Bibliográficos
Autores principales: CUI, CHENGXU, SHU, CHANG, YANG, YI, LIU, JUNBAO, SHI, SHUPING, SHAO, ZHUJUN, WANG, NAN, YANG, TING, HU, SONGNIAN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156196/
https://www.ncbi.nlm.nih.gov/pubmed/25202427
http://dx.doi.org/10.3892/ol.2014.2335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156196/
https://www.ncbi.nlm.nih.gov/pubmed/25202427
http://dx.doi.org/10.3892/ol.2014.2335

Ejemplares similares